Legal Representation
Attorney
Christina M. Licursi, Esq.
USPTO Deadlines
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 27, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 27, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 1, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 1, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 1, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 26, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 2, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 28, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 26, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 26, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 26, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 28, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 26, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 26, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 26, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 26, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 26, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 21, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 21, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 21, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 4, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 27, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 1, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 1, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 12, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 29, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 29, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 29, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 29, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 29, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 1, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 30, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 30, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 31, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 29, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, multigenic disorders, hepatic disorders and disorders of the CNS, none of the foregoing including omega fatty acids
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENOMIC CONTROL"